November 7, 2019
Christoffer Dahl, President and Representative Director, Lundbeck Japan Since its inception in 2001, Lundbeck’s Japan arm has primarily been an R&D outpost of the Danish CNS specialist. This will change with the soon-to-come launch of its antidepressant Trintellix (vortioxetine) in...read more